There isn’t clear publicly available official information on the exact date when the first Cenforce D Extra Power interpreter or product variant became available in the market. Centurion Laboratories, the manufacturer of the Cenforce range of ED and dual‑action combination drugs, has been producing sildenafil and dapoxetine based products for many years, and the combined ED premature ejaculation formulations have been sold increasingly over the last decade.

General industry records indicate that fixed‑dose combinations of sildenafil and dapoxetine for co‑existing erectile dysfunction and premature ejaculation were being approved and marketed by regulatory bodies like India’s DCGI in the early 2020s, reflecting broader availability of these combination products around 2021 and later.

What is clear is that Cenforce D Extra Power (a combination of sildenafil and dapoxetine) has been manufactured and marketed by Centurion Laboratories for several years, and newer variants like the “Extra Power” formulation – typically featuring higher dapoxetine content (e.g., 100 mg) alongside sildenafil – appeared later as part of expanded product lines to offer stronger ejaculatory control.

However, there is no verified public record of the exact initial release date for Cenforce D Extra Power itself. Market listings for these products show they are currently being manufactured and distributed, but exact launch timing isn’t officially documented online.